By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Sucampo Pharmaceuticals, Inc. 

4733 Bethesda Avenue
Suite 450
Bethesda  Maryland  20814  U.S.A.
Phone: 301-961-3400 Fax: 301-961-3440



Start Up

Company News
Sucampo (SCMP) Reports Second Quarter 2016 Financial Results 8/3/2016 10:23:39 AM
Paul Edick Joins Sucampo (SCMP)’s Board Of Directors 7/29/2016 8:13:45 AM
Sucampo (SCMP) Announces Second Quarter 2016 Earnings Call 7/20/2016 8:57:10 AM
Sucampo (SCMP) Terminates Development of Cobiprostone Following Phase II Data 7/11/2016 5:46:12 AM
Sucampo (SCMP) Standardizes On Veeva Systems, Inc. Vault For A Single Source Of Truth Enterprise-Wide 4/28/2016 9:49:11 AM
Sucampo (SCMP) to Terminate Development of Cobiprostone for for PPI-Refractory NERD/SGERD After Trial Failure 4/19/2016 6:01:19 AM
Sucampo (SCMP) Forks Over $190 Million to License Prevention Pharma's Colon Cancer Drug 1/12/2016 6:23:48 AM
Sucampo (SCMP) Provides Update To 2015 And Confirms 2016 Financial Guidance Post Closing Of R-Tech Ueno Acquisition 1/7/2016 8:59:45 AM
Sucampo (SCMP) CEO Peter Greenleaf Appointed Chairman Of The Board Of Directors 12/16/2015 9:07:34 AM
Sucampo (SCMP) Completes Acquisition Of R-Tech Ueno 12/7/2015 8:05:53 AM